In a concerted effort to address misleading online advertising, Attorney General Kwame Raoul has joined forces with a bipartisan group of 35 attorneys general in urging Meta to take decisive steps to regulate its advertisement content related to weight loss drugs. Met with an increase in such ads during peak seasons of body-conscious conversations, Raoul's initiative focuses particularly on the ubiquitous presence of deceptive, AI-generated promotions on platforms like Instagram and Facebook. Although Meta has policies aimed at regulating pharmaceutical and wellness ads, concerns have been raised about the adequacy of their enforcement.
As reported by the Illinois Attorney General's office, many ads for GLP-1 weight loss drugs, which are witnessing a surge in popularity, are either not approved by the FDA or are compounded. The advertisements in question not only aim to quickly capitalize on individuals' insecurities but also often falsely use A.I.-generated images extensively to portray unrealistic and sometimes dangerous weight loss results. Raoul emphasized, “Millions of Americans are looking for help losing weight, and they deserve to know the potential risks and side effects associated with any medications they are considering.”
Meta's existing policies require that information regarding the medical effectiveness and affordability of drugs be shared, and such ads should target only adults. They are also not allowed to promote an “ideal” body type scenario or encourage unhealthy body images. Despite these regulations, there's a troubling trend of ads that gloss over potential health risks and side effects, often selling a flawed concept of self-confidence tightly knotted to physical appearance and social acceptance.
In a move to curb these practices, the attorneys general are pushing for Meta to not only to more stringently enforce current guidelines more stringently but also impose additional restrictions. Among the actions suggested are limiting prescription drug ads in the U.S. exclusively to FDA-approved ones and requiring explicit disclosure of risks when promoting weight loss products. Additionally, the coalition is pressing for a prohibition on weight loss drug ads employing AI-generated content and calling for clearer labeling of such content, coupled with the development of advanced tools that can detect and remove non-compliant materials. These recommendations also extend to redirecting users to safety and educational resources concerning weight loss items when they search for them online.
The call for stricter advertisement supervision by Raoul and his counterparts is indicative of a growing awareness and combat against deceptive marketing, which can negatively impact consumer health. The bipartisan push reflects a shared recognition of the importance of transparency in advertising, particularly within an era where artificial intelligence plays a progressively significant role in content creation. The full roster of attorneys general joining this cause spans states and territories from North Carolina to California and from American Samoa to Washington, showcasing that the imperative of safeguarding consumers from misleading information transcends regional boundaries.
